RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Science
S

Science portfolio

Science has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Rounds led: 1 of 2.
Capital in their rounds: $84M.
Latest deal: Liquid Death · Jan 3, 2022.
About this page

It led 1 of the 2 rounds it joined. Its most recent investment on record is Liquid Death's $75M Series B+ round in January 2022, which it led, alongside Convivialite Ventures, Nomad Venture Fund, GroundForce Capital and 3 others. By category, its portfolio leans toward Sales and marketing (1) and Health and bio (1). It has co-invested with GroundForce Capital, Convivialite Ventures and Chris Nakutis Taylor.

What Science invests in

How Science invests

StageDealsCapital in rounds
Series A 1 50%$9M
Series B+ 1 50%$75M
YearDealsCapital in rounds
2020 1 50%$9M
2022 1 50%$75M

Science portfolio companies

CompanyRound with ScienceTotal raisedLatest raise
LLiquid Death
Sales and marketing
Series B+ · $75M · lead$194MOct 1, 2022
Series B+
CCladwell
Consumer and social
backerundisclosed—

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Sales and marketing).

How this is counted

Share is of the 2 rounds on Recent Funding that name Science. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Science, which is a subset of its real portfolio. API: /api/v1/investors/science (get a free API key). More: the most active VC firms and new venture capital funds.